SHERIDAN, WYOMING - November 25, 2025 - Royal Philips has extended its partnership with quantitative neuroimaging specialist Cortechs.ai to integrate advanced AI-enabled neuroimaging analytics directly into Philips MR systems, giving radiologists faster, more objective and reproducible insights into brain health within their everyday workflows. By combining Philips' next-generation MR technologies with Cortechs.ai's quantitative post-processing software, the collaboration aims to set a new benchmark for precision diagnostics in neurology and strengthen Philips' position in data-driven brain imaging.
Meeting surging demand for brain MR with data-driven insight
Brain imaging is one of the highest-volume MR applications, with up to a quarter of all MR procedures focused on the brain. At the same time, radiology departments are contending with rising numbers of patients with neurological diseases such as Alzheimer's disease, multiple sclerosis and brain tumors, all against a backdrop of staff shortages and increasing case complexity.
Current MR interpretation in neurodegenerative and neuro-oncology cases often relies heavily on visual assessment, demanding deep expertise and time, and introducing variability between readers and sites. The extended Philips-Cortechs.ai partnership addresses this gap by embedding quantitative analysis tools-such as brain volumetrics, lesion quantification and tumor tracking-directly into the MR workflow, giving clinicians numerical biomarkers alongside images to support more consistent, confident decision-making.
AI-powered quantitative neuroimaging inside the MR workflow
A key milestone in the collaboration is the integration of Cortechs.ai's NeuroQuant® solutions for Alzheimer's disease, MS and brain tumors within Philips' Smart Reading environment, a cloud-based AI platform that links imaging, reading and reporting on the MR systems and into PACS. Quantitative reports can be generated automatically in the background and delivered into the standard MR workflow without adding steps for technologists.
The result is a "zero-click" experience for radiologists, who receive standardized, quality-checked outputs as part of their normal reading process. Numerical measures of atrophy, lesion burden or tumor volume support more objective interpretation, follow-up comparison and communication with referring clinicians, while also enabling more structured reporting and research use.
"This integration brings precision, reproducibility, and efficiency to neurological MR, helping clinicians make faster, more confident decisions for patients living with complex brain conditions.
- Ioannis Panagiotelis, PhD, Business Leader, MRI, Philips
"By extending our partnership with Cortechs.ai, we are accelerating the transition to fully quantitative, AI-powered neuroimaging," said Ioannis Panagiotelis, PhD, Business Leader, MRI, Philips. "This integration brings precision, reproducibility, and efficiency to neurological MR, helping clinicians make faster, more confident decisions for patients living with complex brain conditions."
Boosting productivity while supporting precision brain care
The extended partnership fits into Philips' broader strategy of using deep AI integration to tackle system-level pressures in healthcare-from workforce shortages to growing demand for advanced diagnostics. Automatically generated, quantitative reports reduce manual post-processing and help radiology teams save time while improving consistency and throughput across sites and scanners.
Objective neuroimaging biomarkers also support more reproducible longitudinal assessments, making it easier to track disease progression or treatment response over time. With quality-controlled workflows and standardized outputs, technologists can focus more on patient experience, while clinicians can rely on quantitative data to personalize care pathways for people living with complex neurological conditions.
Cortechs.ai analytics as a catalyst for personalized neurology
For Cortechs.ai, the partnership significantly broadens access to its AI-driven neuroanalytics within routine clinical MR environments. NeuroQuant® solutions, already available on Philips Advanced Visualization Workspace, will now be natively integrated into Philips' MR platform and AI infrastructure, further lowering the barrier to adoption for hospitals and imaging networks.
"Cortechs.ai's mission has always been to empower clinicians with actionable, quantitative insights," said Kyle Frye, Chief Executive Officer, Cortechs.ai. "By combining our advanced neuro analytics with Philips' leading MR platform and AI infrastructure, we're making it easier to personalize brain care and track neurological changes with precision."
Toward a new standard in precision neuro diagnostics
By embedding quantitative neuroimaging directly into MR acquisition, reading and reporting, Philips and Cortechs.ai are helping to move neurology toward a more standardized, data-rich model of care. The collaboration is designed not only to enhance diagnostic accuracy, but also to enable more efficient workflows, scalable research, and consistent care across multi-site networks.
Cortechs.ai's NeuroQuant® portfolio on Philips platforms illustrates how AI-enabled neuroimaging can become a core component of precision diagnostics rather than an add-on tool. With this extended partnership, Philips reinforces its commitment to advancing neurology and enabling providers to deliver better brain care for more patients, in less time, and with greater confidence.
To learn more about Philips' MR portfolio and its collaboration with Cortechs.ai in quantitative neuroimaging, visit https://www.philips.com/global.